Skip to main content
Premium Trial:

Request an Annual Quote

SciLifeLab, KTH Royal Institute of Technology: Tuuli Lappalainen

Tuuli Lappalainen has been appointed as director of the National Genomics Infrastructure (NGI) at the Science for Life Laboratory (SciLifeLab) in Sweden. She will also become a professor of chemistry, biotechnology, and health at the KTH Royal Institute of Technology School of Engineering Sciences. Lappalainen, who is currently a core member of the New York Genome Center and an associate professor of systems biology at Columbia University, will take up her new posts May 15. She will continue to be an associate faculty member of the NYGC and will maintain her lab at the center.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.